Featured Research

from universities, journals, and other organizations

Researchers Zero In On Estrogen's Role In Breast-cancer Cell Growth

Date:
September 9, 2005
Source:
University of Illinois at Urbana-Champaign
Summary:
Why do estrogen-dependent breast-cancer cells grow and spread rapidly? Researchers at the University of Illinois at Urbana-Champaign say it may be because estrogen virtually eliminates levels of a vitally important regulatory protein.

Jonna Frasor, a postdoctoral researcher, left, and Benita S. Katzenellenbogen, a Swanlund Professor of Cell and Developmental Biology, report that human breast-cancer cells exposed to estrogen in their laboratory showed a dramatic reduction in numbers of a crucial nuclear receptor corepressor, a protein known as N-CoR.
Credit: Photo by Kwame Ross

CHAMPAIGN, Ill. -- Why do estrogen-dependent breast-cancer cells growand spread rapidly? Researchers at the University of Illinois atUrbana-Champaign say it may be because estrogen virtually eliminateslevels of a vitally important regulatory protein.

Related Articles


In a paper that will appear in the Sept. 13 issue of the Proceedingsof the National Academy of Sciences, the scientists report that humanbreast-cancer cells exposed to estrogen in their laboratory showed adramatic reduction in numbers of a crucial nuclear receptorcorepressor, a protein known as N-CoR (pronounced "en CORE"). They alsofound that the anti-estrogen drug tamoxifen, often used inbreast-cancer treatments, encouraged N-CoR recovery, a beneficialactivity. The paper was published online last week.

"Because estrogen has the ability to reduce the levels ofN-CoR, estrogen then can promote the proliferation and progression ofbreast cancer, because the balance of co-activators and co-repressorsinvolved in normal gene transcription is altered," said Benita S.Katzenellenbogen, a Swanlund Professor of Cell and DevelopmentalBiology at Illinois. She also is a professor of molecular andintegrative physiology.

The findings may have sweeping implications, saidKatzenellenbogen and lead author Jonna Frasor, a postdoctoralresearcher who joins the faculty of the department of physiology andbiophysics in the U. of I. College of Medicine at Chicago this month.

For one, the mechanisms at play could explain at least some ofthe mixed results seen in women using estrogen and progesterone inhormone therapy, said Katzenellenbogen, who also is a professor in theU. of I. College of Medicine at Urbana-Champaign.

While numbers of N-CoR proteins fell to 20 percent of normal,the level of N-CoR's messenger RNA went untouched. The reduction ofN-CoR followed an up regulation of the ubiquitin ligase Siah2, anenzyme that targets certain proteins for degradation, Frasor said.

"Here we had an effect on the level of the N-CoR proteinwithout affecting the level of N-CoR mRNA," Katzenellenbogen said."This is the result of the initial effect of estrogen on geneexpression, which was to up regulate the mRNA levels for a ubiquitinligase. So by changing the level of this ligase, it had a dramaticeffect on the level of N-CoR protein without affecting gene expressionfor N-CoR itself."

This "secondary effect" may have broad implications for otherimportant cellular activities, the researchers theorize. Reductions inN-CoR over time also could promote cancer development in other sites,such as the uterus, and could adversely affect the desired activitiesof vitamin D, retinoid and thyroid receptors, Katzenellenbogen said.

The study sheds light on the impact of estrogen on certaincells, as well as how tamoxifen works as an anti-estrogen to facilitaterecovery of N-CoR, she and Frasor said.

"Eventually," Katzenellenbogen said, "understanding more of themechanisms involved could lead to the development of other relatedagents that might reduce some of the unwanted side effects oftamoxifen, such as stimulation of the uterus."

In addition to Katzenellenbogen and Frasor, Jeanne M. Danes, aresearcher in the department of molecular and integrative physiology,and doctoral student Cory C. Funk were co-authors of the study.

###

The National Institutes of Health and the Breast Cancer Research Foundation funded the research.


Story Source:

The above story is based on materials provided by University of Illinois at Urbana-Champaign. Note: Materials may be edited for content and length.


Cite This Page:

University of Illinois at Urbana-Champaign. "Researchers Zero In On Estrogen's Role In Breast-cancer Cell Growth." ScienceDaily. ScienceDaily, 9 September 2005. <www.sciencedaily.com/releases/2005/09/050909074901.htm>.
University of Illinois at Urbana-Champaign. (2005, September 9). Researchers Zero In On Estrogen's Role In Breast-cancer Cell Growth. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2005/09/050909074901.htm
University of Illinois at Urbana-Champaign. "Researchers Zero In On Estrogen's Role In Breast-cancer Cell Growth." ScienceDaily. www.sciencedaily.com/releases/2005/09/050909074901.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins